We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0R55 market cap is 468.69M. The company's latest EPS is EUR -0.0168 and P/E is -0.60.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 5.08M | 3.32M | 4.21M | 312k | 316k |
| Operating Income | -11.45M | -11.17M | -17.39M | -877k | -2.31M |
| Net Income | -14.22M | -10.46M | -11.94M | -984k | -2.04M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 25.75M | 22.39M | 24.84M | 1.16M | 29.32M |
| Total Liabilities | 21.26M | 20.35M | 21.51M | 3.83M | 26.2M |
| Total Equity | 4.49M | 2.05M | 3.33M | -2.67M | 3.12M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -12.9M | -10.4M | -16.08M | -1.07M | -1.91M |
| Investing | -295k | -302k | 11.91M | N/A | 1.95M |
| Financing | 12.96M | 11.16M | 10.19M | 1.17M | 1.05M |
| Market Cap | 468.69M |
| Price to Earnings Ratio | -0.60 |
| Price to Sales Ratio | 3.85 |
| Price to Cash Ratio | 0.66 |
| Price to Book Ratio | 0.39 |
| Dividend Yield | - |
| Shares Outstanding | 121.9M |
| Average Volume (1 week) | 4.52k |
| Average Volume (1 Month) | 4.18k |
| 52 Week Change | 0.00% |
| 52 Week High | 3.845 |
| 52 Week Low | 3.845 |
| Spread (Intraday) | 0.19 (4.82%) |
| Company Name | Bone Therapeutics Sa |
| Address |
rue granbonpre 11 , batiment h (bte 24) mont-saint-guibert, walloon brabant 1435 |
| Website | https://www.bonetherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
